You are viewing: India Plasma Fractionation Market analysis
Part of: Plasma Fractionation Market (Global)

The India Plasma Fractionation Market was valued at $300.4 Million in 2026 and projected to reach to $432.2 Million by 2031, representing a compound annual growth rate of 7.5%. India's plasma fractionation market is poised for sustained growth driven by rising awareness of plasma-derived therapies, increasing diagnosis rates of immunodeficiency and coagulation disorders, and government initiatives promoting blood safety and plasma collection.

India Plasma Fractionation Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Plasma Fractionation Market Trends and Insights

  • Valued at USD 300.4 million in 2026, India's market is expected to expand to USD 432.2 million by 2031, reflecting a compound annual growth rate of 7.5%.
  • This growth trajectory underscores India's increasing demand for plasma-derived therapies, driven by rising immunodeficiency disorders, bleeding disorders, and chronic disease prevalence across the nation. India's plasma fractionation sector benefits from expanding healthcare infrastructure, growing awareness of plasma therapies, and supportive regulatory frameworks.
  • The market in India is characterized by a mix of domestic manufacturers and international players competing to meet the country's substantial patient population needs.
  • Between 2026 and 2031, India's market expansion will be fueled by improved access to treatment, rising healthcare expenditure, and enhanced cold-chain capabilities across urban and semi-urban regions. The trajectory from 2026 to 2031 positions India as a high-growth market within the Asia Pacific region, with opportunities for both established and emerging plasma fractionation providers to capture market share in this dynamic healthcare economy..

Key Market Statistics

  • CAGR (2026-2031) 7.5% CAGR
  • Market Size, 2026 ~USD 300.4 Million
  • Forecast, 2031 ~USD 432.2 Million
  • Country India

India Plasma Fractionation Market Overview

Market Valuation Growth :

India's plasma fractionation market is valued at USD 300.4 million in 2026 and is projected to reach USD 432.2 million by 2031, representing a robust 7.5% CAGR aligned with global expansion trends.

Rising Immunodeficiency Cases :

Increasing prevalence of immunodeficiency disorders and bleeding disorders across India's population is driving demand for plasma-derived immunoglobulins, clotting factors, and albumin therapies.

Healthcare Infrastructure Expansion :

India's growing healthcare infrastructure, improved cold chain logistics, and expanding hospital networks are enhancing accessibility to plasma fractionation products across urban and semi-urban regions.

Asia Pacific Strategic Position :

As a key player in Asia Pacific's healthcare landscape, India represents significant growth potential due to its large patient population, cost-effective manufacturing capabilities, and increasing healthcare spending.

India Plasma Fractionation Market Dynamics

  • The expanding middle class and improved healthcare accessibility in tier-2 and tier-3 cities are creating new patient populations requiring these critical therapies.
  • Regulatory support for domestic plasma collection and fractionation facilities is expected to strengthen India's self-sufficiency in plasma products.
  • Additionally, partnerships between Indian manufacturers and global players are facilitating technology transfer and product innovation, positioning India as both a significant market and manufacturing hub for plasma fractionation products in the Asia Pacific region..

Market Ecosystem

logo-mobile

PLASMA FRACTIONATION MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
company logo
Implemented the Horizon 2 plasma fractionation process at its Kankakee facility to improve immunoglobulin recovery from donated plasma Higher immunoglobulin yield | Improved plasma utilization | Greater production efficiency | Increased supply capacity
company logo
Implemented process improvements through its One Day Batch Release program at plasma-derived therapy manufacturing sites to accelerate batch release Faster batch release | Improved manufacturing efficiency | Shorter lead times | Faster product availability

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • SANOFI
    • Pfizer Inc.
    • NOVARTIS

      Key Takeaways

      • India's plasma fractionation market will grow from USD 300.4 million in 2026 to USD 432.2 million in 2031 at a 7.5% CAGR.
      • India's market expansion is driven by rising prevalence of immunodeficiency and bleeding disorders across the nation's large patient population.
      • India's healthcare infrastructure improvements and regulatory support are enabling wider access to plasma-derived therapies.
      • India represents a high-growth opportunity within Asia Pacific, attracting both domestic and international plasma fractionation manufacturers.

      Plasma Fractionation Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment SCIG (Type)
      Forecast Period 2026-2030
      Growth Rate CAGR of 7.6% from 2026 to 2030
      Largest Segment THERAPEUTICS (Application)
      Market Size Base Year (Billions) ~USD 36.46 (2026)
      Revenue Forecast (Billions) ~USD 48.87 (2030)
      Segments Covered Product, Type, Application, Therapeutic Area, End User

      India Plasma Fractionation Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Product

      • Albumin
      • Coagulation Factor Concentrates
      • Immunoglobulins
      • Other Plasma Products
      • Protease Inhibitors

      By Type

      • Factor Ix
      • Factor Viii
      • Factor Xiii
      • Fibrinogen Concentrates
      • Ivig
      • Other Coagulation
      • Other Coagulation Factor Concentrates
      • Other Immunoglobulins
      • Prothrombin Complex Concentrates
      • Prothrombin Factor Concentrates
      • Scig
      • Von Willebrand Factor

      By Application

      • Academics & Preclinical Research
      • Therapeutics

      By Therapeutic Area

      • Critical Care
      • Hemato-Oncology
      • Hematology
      • Immunology
      • Neurology
      • Other Therapeutic Areas
      • Pulmonology
      • Rheumatology

      By End User

      • Home Care Settings & Infusion Centers
      • Hospitals & Specialty Clinics
      • Other End Users

      Target Audience

      • Pharmaceutical & Biotech Companies : Manufacturers and distributors of plasma fractionation products need India-specific market data to evaluate market entry strategies, assess competitive positioning, and identify growth opportunities in immunoglobulin and clotting factor segments.
      • Healthcare Investors & PE Firms : Investment professionals require detailed India market analysis to evaluate portfolio opportunities in plasma fractionation, assess growth potential, and make informed decisions on healthcare sector investments in India.
      • Hospital & Clinical Networks : Healthcare facility operators need market insights to understand plasma product demand trends, optimize procurement strategies, and plan inventory management for immunodeficiency and bleeding disorder treatments.
      • Government & Regulatory Bodies : Indian health ministry officials and regulatory agencies require market intelligence to develop blood safety policies, plasma collection initiatives, and self-sufficiency programs aligned with market growth projections.
      • Market Research & Consulting Firms : Research organizations and consultants need comprehensive India-specific data to support client advisory services, competitive analysis, and strategic recommendations in the plasma fractionation and broader healthcare sectors.

      Reasons to Buy this Report

      • Market Size & Growth Projections : Access precise valuation data for India's plasma fractionation market with detailed forecasts from 2026-2031, enabling accurate financial planning and investment decisions specific to the Indian healthcare sector.
      • India-Specific Demand Drivers : Understand unique factors driving India's 7.5% CAGR including rising immunodeficiency cases, expanding healthcare infrastructure, and government blood safety initiatives that differentiate India from other regional markets.
      • Competitive Landscape Intelligence : Gain insights into India's domestic plasma fractionation manufacturers, international player strategies, regulatory environment, and market consolidation trends to identify partnership and expansion opportunities.
      • Regional Market Positioning : Benchmark India's performance against Asia Pacific trends and understand its strategic importance as both a high-growth market and emerging manufacturing hub for plasma-derived products.
      • Strategic Business Planning : Leverage India-focused market intelligence for product localization, pricing strategies, distribution channel optimization, and go-to-market planning tailored to India's unique healthcare ecosystem and patient demographics.

      Frequently asked questions

      What is the projected market size of plasma fractionation in India by 2031?

      India's plasma fractionation market is projected to reach USD 432.2 million by 2031, up from USD 300.4 million in 2026.

      What is the CAGR for India's plasma fractionation market?

      India's plasma fractionation market is expected to grow at a compound annual growth rate of 7.5% between 2026 and 2031.

      What factors are driving growth in India's plasma fractionation market?

      India's market growth is driven by rising immunodeficiency disorders, bleeding disorders, expanding healthcare infrastructure, improved regulatory frameworks, and increased awareness of plasma therapies.

      How does India's plasma fractionation market compare to the global market?

      India's 7.5% CAGR aligns closely with the global market CAGR of 7.6%, positioning India as a key growth contributor within the Asia Pacific region.

      What is the estimated market size of plasma fractionation in India in 2026?

      India's plasma fractionation market is estimated at USD 300.4 million in 2026, serving as the baseline for the forecast period through 2031.

      RESEARCH METHODOLOGY

      This research study extensively used secondary sources, directories, and databases to identify and collect valuable information for analyzing the global plasma fractionation market. In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market's growth prospects. The global market size estimated through secondary research was triangulated with inputs from primary research to determine the final market size..

      Secondary Research

      The secondary sources for this research study include publications from government sources, such as FDA/CBER, EMA, WHO, and national health and regulatory authorities; industry associations, such as the Plasma Protein Therapeutics Association (PPTA), the International Plasma and Fractionation Association (IPFA), and AABB; and commercial databases, such as Bloomberg Business, D&B, Factiva, and relevant trade databases. Additional sources include white papers, annual reports, company house documents, investor presentations, scientific and clinical publications, regulatory filings, patent databases, and product and clinical trial databases. Secondary research was used to identify and collect information for the extensive, technical, market-oriented, and commercial study of the plasma fractionation market. It was also used to obtain important information about key players, market classification, segmentation according to industry trends, the bottom-up approach, and key developments from market and technology perspectives. Secondary data was also used to assess plasma collection capacity, fractionation and manufacturing infrastructure, product portfolios, regulatory frameworks, trade patterns, clinical applications, and regional market trends. These sources were also used to gather key information about major players, market classification, and segmentation based on industry trends, regional/country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess the market’s prospects. Primary sources from both the supply and demand sides of the market were interviewed to gather qualitative and quantitative information.

      Plasma Fractionation Market
 Size, and Share

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the plasma fractionation market. These methods were also used extensively to estimate the size of various market segments.

      Plasma Fractionation Market : Top-Down and Bottom-Up Approach

      Plasma Fractionation Market Top Down and Bottom Up Approach

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.

      Market Definition

      Plasma-derived therapies are medical treatments based on human plasma. Plasma is the largest component of human blood and contains water, salts, enzymes, antibodies, and other proteins. Before it can be used in medical therapies, it undergoes a fractionation process in which the relevant proteins are separated. Plasma-derived therapies are used to treat a wide range of (rare) diseases, from bleeding disorders and inhibitor deficiencies to primary and secondary immunodeficiencies.

      Key Stakeholders

      • Plasma Fractionation Product Manufacturers and Distributors
      • Pharmaceutical and Biotechnology Companies
      • Healthcare Service Providers (including Hospitals and Clinics)
      • Research and Development (R&D) companies
      • Academic Institutes
      • Government Associations
      • Market Research and Consulting Firms
      • Venture Capitalists and Investors

      Report Objectives

      • To define, describe, and forecast the plasma fractionation market based on product, application, therapeutic area, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall plasma fractionation market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the plasma fractionation market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the plasma fractionation market
      • To benchmark players within the plasma fractionation market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product/service strategy

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

      Product Analysis

      • Further breakdown of the Rest of Europe Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Asia Pacific Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Latin America Plasma Fractionation Market, by country
      • Further breakdown of the Rest of Middle East Plasma Fractionation Market, by country

      Company Information

      • Detailed analysis and profiling of additional market players (up to five)

      Get the Full Plasma Fractionation Market Report

      Full forecast, segment splits, and company analysis for all Plasma Fractionation Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status